Can circulating tumor cells predict resistance in Metastatic breast cancer?

Aju Mathew, Adam M. Brufsky, Nancy E. Davidson

Research output: Contribution to journalArticle

Abstract

Circulating tumor cell (CTC) enumeration provides prognostic but not predictive information for chemotherapy in metastatic breast cancer. Because CTC measurement is reproducible and allows molecular profiling, an assay to assess endocrine resistance was developed. Whether this CTC-based assay can be used to reliably select endocrine therapy must be tested.

Original languageEnglish (US)
Pages (from-to)2421-2423
Number of pages3
JournalClinical Cancer Research
Volume21
Issue number11
DOIs
StatePublished - Jun 1 2015

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Can circulating tumor cells predict resistance in Metastatic breast cancer?'. Together they form a unique fingerprint.

  • Cite this